ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

CGAP Speeding Gene Discovery

April 30, 1999

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Funding Opportunities

September 6, 2002

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981